Advertisement

Diabetes and Endocrinology

Home Diabetes and Endocrinology
Empagliflozin is associated with improved beta cell function in subjects with impaired fasting glucose

Empagliflozin Ups β Cell Function in Impaired Fasting Glucose

Empagliflozin produces comparable glucosuria in subjects with impaired, normal fasting glucose
Acupuncture received mixed reviews in two new studies -- one focusing on stress incontinence and the other on polycystic ovary syndrome-related infertility. The research was published in the June 27 issue of the Journal of the American Medical Association.

Mixed Results on Acupuncture for Incontinence, Infertility

Benefit seen in stress incontinence; no benefit for infertility in polycystic ovary syndrome
New measures to increase the number of generic prescription drugs available to Americans have been taken by the U.S. Food and Drug Administration.

FDA Seeks to Increase Number of Generic Drugs on Market

Agency will now give priority reviews to new generic drugs until there are at least three available
Implementation of an intervention

Intervention Ups Appropriate Dysglycemia Screening

Screening doubled after intervention, which included EHR-based decision support, training
The prevalence of diabetes is 10.9 percent in China

Estimated Prevalence of Diabetes 10.9 Percent in China

Overall, 36.5 percent of those with diabetes were aware of their diabetes, 32.2 percent were treated
Optimal management of coexisting type 2 diabetes and osteoporosis should consider the scientific evidence

Review Spotlights Optimal Care of T2DM + Osteoporosis

Preferred T2DM meds are sulfonylureas, DPP-4is, GLP-1 receptor agonists
From 1991 to 2014 there was minimal change in health spending by state

1991-2014 Saw Minimal Change in Health Spending Per State

Recession and recovery, implementation of health reform impacted health care coverage
Shiftworkers

Occupation Tied to Risk of Vitamin D Deficiency

Findings may help target health promotion and preventive efforts, researchers say
Serum levels of soluble receptor for advanced glycation end products are associated with the risk of developing incident diabetic nephropathy in individuals with type 1 diabetes

sRAGE Linked to Risk of Incident Diabetic Nephropathy

Independent link seen for soluble receptor for advanced glycation end products, but not for CML
Demonstration sites

Medical-Home Recognition Higher in Demonstration Sites

Smaller decreases in number of visits to federally-qualified health centers for demonstration sites